query_list = ['basal cell carcinoma, PTCH1, 56 year, female', 'glioma, BRAF, 82 year, male', 'thyroid cancer, BRAF, 40 year, female', 'lung cancer, FGFR1, 57 year, male', 'prostate cancer, PTEN, 70 year, male', 'melanoma, BRAF (V600E), PTEN loss of function, 57 year, male', 'adenoid cystic carcinoma, KIT, 58 year, female', 'melanoma, KIT (L576P), 65 year, female', 'acute myeloid leukemia, IDH1, 1 year, male', 'melanoma, BRAF (V600E), NRAS (Q61R), 67 year, male', 'acute myeloid leukemia, FLT3, 13 year, male', 'melanoma, BRAF amplification, 61 year, male', 'melanoma, NRAS (Q61R), 63 year, female', 'melanoma, NRAS (Q61L), 34 year, female', 'melanoma, KIT (L576P), KIT amplification, 56 year, female', 'melanoma, KIT (K642E), 62 year, female', 'melanoma, KIT (N822Y), 39 year, female', 'melanoma, KIT amplification, 66 year, female', 'melanoma, BRAF (K601E), 38 year, male', 'melanoma, BRAF (V600E), 64 year, male', 'melanoma, NF1 truncation, 70 year, male', 'melanoma, NTRK1 rearrangement, 60 year, male', 'melanoma, TP53 loss of function, 72 year, male', 'melanoma, BRAF (V600K), 54 year, male', 'melanoma, tumor cells with >50% membranous PD L1 expression, 48 year, female', 'melanoma, tumor cells negative for PD L1 expression, 73 year, male', 'melanoma, high tumor mutational burden, 86 year, female', 'melanoma, extensive tumor infiltrating lymphocytes, 49 year, male', 'melanoma, no tumor infiltrating lymphocytes, 74 year, female', 'melanoma, PTEN loss of function, 68 year, male', 'melanoma, APC loss of function, 47 year, male', 'melanoma, high serum LDH levels, 69 year, female', 'melanoma, BRAF (V600R), 80 year, male', 'colorectal cancer, NRAS, 49 year, male', 'medullary thyroid carcinoma, RET, 45 year, female', 'neuroblastoma, ALK, 4 year, female', 'esophageal cancer, EGFR, 67 year, male', 'lung cancer, ROS1, 71 year, female', 'head and neck squamous cell carcinoma, CDKN2A, 64 year, male', 'leukemia, ABL1, 4 year, female', 'gastric cancer, EGFR, 60 year, female', 'sarcoma, MDM2, 78 year, female', 'breast cancer, CDKN2A, 73 year, female', 'lung cancer, ERBB2, 49 year, female', 'non small cell carcinoma, MET, 68 year, male', 'cholangiocarcinoma, IDH1, 50 year, male', 'anaplastic large cell lymphoma, ALK, 18 year, male', 'breast cancer, ERBB2, 56 year, female', 'papillary thyroid carcinoma, NTRK1, 46 year, female', 'glioblastoma, CDK6, 84 year, male']
